@geraldt52
Thanks Gerald. I've been following the Lipkin developments closely for, well, however long it is, and I was totally bowled over by this conference video. The range, depth and breadth of the research program is staggering. I'm not even sure that I knew they had a gene expression study on the go. I feel exceptionally lucky that we have this team on our side. They clearly want to find answers, despite struggling to attract funds. I think the academic challenge of the subject must intrigue them. But they also know the patient community now, so they have a personal investment. The sophistication of their program is impressive. They are looking for 1.7m viruses, and antibodies to them. And they are now delving into autoimmunity, looking for autoantibodies. That's on top of the proteomics and metabolomics etc. The amount of data they're going to have is utterly phenomenal. I've no idea how they're going to process it all. And they want to connect dots, to make associations between various immune markers and genes and signs of pathogens. If I understood correctly, they also want to dig deeper than simply looking for autoantibodies, and to look to see if any autoantibodies are related to genes or genetic markers. And to see if there are any signs of infection that may have triggered or precipitated an autoimmune reaction. And I'm not sure if that's been done rigorously in science at all yet? Perhaps it has but I'm not aware of it. This is a truly cutting edge, and thorough, scientific program. How did we manage to get this team on board? I mean one of the most elite scientific teams on the planet!